Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Statin Treatment for Atherosclerotic Vascular Disease (STA study)
KCT0001730Phase 4Recruiting
- Sponsor
- JW Pharmaceutical Corporation
- Start
- Jun 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of ulinastatin in acute coronary syndrome (ACS), atherosclerotic disease, sponsored by JW Pharmaceutical Corporation. Started Jun 2015; status: recruiting.
02
Drugs
ulinastatin
03
Conditions
acute coronary syndrome (ACS)atherosclerotic disease
Beyond the preview
Go deeper on KCT0001730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001730.